Scibase AB (SCIB) - Net Assets

Latest as of March 2026: Skr58.11 Million SEK ≈ $6.25 Million USD

Based on the latest financial reports, Scibase AB (SCIB) has net assets worth Skr58.11 Million SEK (≈ $6.25 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr103.69 Million ≈ $11.16 Million USD) and total liabilities (Skr45.58 Million ≈ $4.91 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Scibase AB strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Skr58.11 Million
% of Total Assets	56.04%
Annual Growth Rate	N/A
5-Year Change	-90.6%
10-Year Change	-96.41%
Growth Volatility	228.07

Scibase AB - Net Assets Trend (2012–2025)

This chart illustrates how Scibase AB's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Scibase AB (SCIB) market capitalisation.

Annual Net Assets for Scibase AB (2012–2025)

The table below shows the annual net assets of Scibase AB from 2012 to 2025. Also explore Scibase AB (SCIB) equity growth momentum to track the company's year-over-year net asset growth rate.

Year	Net Assets	Change
2025-12-31	Skr6.66 Million ≈ $716.29K	-81.84%
2024-12-31	Skr36.65 Million ≈ $3.94 Million	-14.88%
2023-12-31	Skr43.06 Million ≈ $4.63 Million	+70.61%
2022-12-31	Skr25.24 Million ≈ $2.72 Million	-64.35%
2021-12-31	Skr70.80 Million ≈ $7.62 Million	+51.08%
2020-12-31	Skr46.86 Million ≈ $5.04 Million	+46.38%
2019-12-31	Skr32.01 Million ≈ $3.45 Million	-55.21%
2018-12-31	Skr71.48 Million ≈ $7.69 Million	-38.23%
2017-12-31	Skr115.72 Million ≈ $12.45 Million	-37.58%
2016-12-31	Skr185.41 Million ≈ $19.95 Million	-36.38%
2015-12-31	Skr291.42 Million ≈ $31.36 Million	+792.69%
2014-12-31	Skr32.65 Million ≈ $3.51 Million	-9.77%
2013-12-31	Skr36.18 Million ≈ $3.89 Million	+252.73%
2012-12-31	Skr-23.69 Million ≈ $-2.55 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Scibase AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 80241125900.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Common Stock	Skr20.71 Million	311.13%
Other Comprehensive Income	Skr5.36 Million	80.56%
Other Components	Skr807.00 Million	12124.34%
Total Equity	Skr6.66 Million	100.00%

Scibase AB Competitors by Market Cap

The table below lists competitors of Scibase AB ranked by their market capitalization.

Company	Market Cap
J and Friends Holdings Limited NASDAQ:JF	$17.06 Million
Kainos Group PLC LSE:KNOS	$17.06 Million
N.C. Housing Public Company Limited BK:NCH	$17.08 Million
SUNL.TECH.G.ADR/2DL-00005 F:S790	$17.08 Million
Four Seasons Education Cayman NYSE:FEDU	$17.05 Million
Trigon Metals Inc V:TM	$17.04 Million
Fiplasto SA BA:FIPL	$17.03 Million
Scan Inter PCL BK:SCN	$17.02 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Scibase AB's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 36,650,000 to 6,656,000, a change of -29,994,000 (-81.8%).
Net loss of 87,063,000 reduced equity.
New share issuances of 83,796,000 increased equity.
Other comprehensive income increased equity by 4,642,000.
Other factors decreased equity by 31,369,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Skr-87.06 Million	-1308.04%
Share Issuances	Skr83.80 Million	+1258.95%
Other Comprehensive Income	Skr4.64 Million	+69.74%
Other Changes	Skr-31.37 Million	-471.29%
Total Change	Skr-	-81.84%

Book Value vs Market Value Analysis

This analysis compares Scibase AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 10.07x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2012-12-31	Skr-33.64	Skr15.50	x
2013-12-31	Skr428.21	Skr15.50	x
2014-12-31	Skr386.39	Skr15.50	x
2015-12-31	Skr2488.21	Skr15.50	x
2016-12-31	Skr1275.49	Skr15.50	x
2017-12-31	Skr777.46	Skr15.50	x
2018-12-31	Skr250.83	Skr15.50	x
2019-12-31	Skr114.99	Skr15.50	x
2020-12-31	Skr1.45	Skr15.50	x
2021-12-31	Skr109.53	Skr15.50	x
2022-12-31	Skr35.77	Skr15.50	x
2023-12-31	Skr39.87	Skr15.50	x
2024-12-31	Skr20.59	Skr15.50	x
2025-12-31	Skr1.54	Skr15.50	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Scibase AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -1308.04%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -215.18%
• Asset Turnover: 0.78x
• Equity Multiplier: 7.84x
Recent ROE (-1308.04%) is below the historical average (-178.50%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2012	0.00%	0.00%	0.00x	0.00x	Skr-38.60 Million
2013	-219.75%	-81960.82%	0.00x	1.21x	Skr-83.12 Million
2014	-118.72%	-2422.19%	0.04x	1.27x	Skr-42.02 Million
2015	-14.25%	-1000.53%	0.03x	0.53x	Skr-70.67 Million
2016	-28.63%	-824.83%	0.06x	0.55x	Skr-71.63 Million
2017	-36.69%	-619.10%	0.05x	1.11x	Skr-54.04 Million
2018	-61.86%	-640.89%	0.09x	1.13x	Skr-51.36 Million
2019	-123.51%	-426.25%	0.20x	1.44x	Skr-42.74 Million
2020	-74.67%	-367.49%	0.16x	1.26x	Skr-39.67 Million
2021	-58.89%	-355.50%	0.14x	1.21x	Skr-48.77 Million
2022	-158.10%	-223.02%	0.36x	1.98x	Skr-42.42 Million
2023	-129.10%	-239.13%	0.36x	1.49x	Skr-59.89 Million
2024	-166.78%	-205.77%	0.48x	1.68x	Skr-64.79 Million
2025	-1308.04%	-215.18%	0.78x	7.84x	Skr-87.73 Million

Industry Comparison

This section compares Scibase AB's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $444,166,993
Average return on equity (ROE) among peers: -52.67%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Scibase AB (SCIB)	Skr58.11 Million	0.00%	0.78x	$17.06 Million
Acarix A/S (ACARIX)	$82.14 Million	-50.58%	0.10x	$27.09 Million
Arcoma AB (ARCOMA)	$59.33 Million	18.84%	0.36x	$12.26 Million
Bactiguard Holding AB (publ) (BACTI-B)	$373.35 Million	-10.28%	0.81x	$51.78 Million
BICO Group AB (BICO)	$3.01 Billion	-0.18%	0.82x	$168.00 Million
Boule Diagnostics AB (BOUL)	$199.69 Million	5.49%	0.38x	$10.66 Million
CellaVision AB (CEVI)	$429.62 Million	20.83%	0.55x	$423.52 Million
Clinical Laserthermia Systems AB (publ) (CLS-B)	$17.06 Million	-157.93%	0.60x	$9.53 Million
Chordate Medical Holding AB (CMH)	$35.72 Million	-45.19%	0.33x	$29.05K
C-Rad AB (publ) (CRAD-B)	$231.09 Million	10.86%	0.33x	$122.03 Million
Duearity AB (DEAR)	$6.06 Million	-318.56%	0.99x	$331.97K

About Scibase AB

ST:SCIB Sweden Medical Devices

Market Cap

$17.06 Million

Skr158.49 Million SEK

Market Cap Rank

#25695 Global

#521 in Sweden

Share Price

Skr15.50

Change (1 day)

-3.13%

52-Week Range

Skr0.21 - Skr50.80

All Time High

Skr50.80